On a per-share basis, the Rahway, New Jersey-based company said it had profit of $1.48. Earnings, adjusted for one-time gains and costs, came to $1.72 per share. The results surpassed Wall Street ...
Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused about its prospects in 2025.
The Associated Press - Business News on MSN11d
Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in ChinaShares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...
Merck swung to a quarterly profit as sales grew to beat Wall Street’s estimates, though the drug company’s outlook for 2025 ...
Merck (MRK) shares drop 8% premarket as 2025 outlook falls short of Wall Street estimates, despite beating Q4 expectations ...
Merck & Co. (MRK) on Tuesday reported fourth-quarter net income of $3.74 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $1.48. Earnings, adjusted for one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results